John Burns
Director Financiero/CFO en SELLAS LIFE SCIENCES GROUP, INC. .
Fortuna: 141 995 $ al 30/04/2024
Perfil
John T.
Burns is currently the Chief Financial Officer & Accounting Officer, SVP at SELLAS Life Sciences Group, Inc. He previously worked as the Manager-Securities & Exchange Reporting at Pixelworks, Inc. and as the Chief Accounting Officer at Galena Biopharma, Inc. Mr. Burns completed his undergraduate and graduate degrees at Tulane University (Louisiana).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/01/2024 | 93 418 ( 0.17% ) | 141 995 $ | 30/04/2024 |
Cargos activos de John Burns
| Empresas | Cargo | Inicio |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director Financiero/CFO | 30/12/2017 |
Antiguos cargos conocidos de John Burns.
| Empresas | Cargo | Fin |
|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Formación de John Burns.
| Tulane University (Louisiana) | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John Burns
